Purpose: The acute-on-chronic exacerbations of end-stage respiratory diseases often result in prolonged hospital stays, relating these events to ethical conflicts in the fields of medical futility and distributive justice. This study aimed to understand patients' preferences for life-sustaining treatments when clinically stable and during regular follow-up visits, and to determine the factors that can influence these preferences. Procedure: This was a prospective, observational, exploratory study using convenience sampling. Over a three-year period, the study enrolled 106 adult outpatients with end-stage pulmonary disease on long-term oxygen treatment with/ without noninvasive mechanical ventilation with dyspnoea scores of 6 or more in the modified Borg dyspnoea scale and one of the following: Gold (chronic obstructive pulmonary disease classification) stage IV, diffusing capacity (DLCO) <40%, heart failure (New York Heart Association functional classification (NYHA)) stage III/IV, or systolic pulmonary artery pressure 40 mm Hg. Results: Factors that were influential in preferences were age, gender, household status, NYHA class, and previous exposure to mechanical ventilation. Conclusions: There was no consensus on life-sustaining treatment preferences. Demographic factors, such as age group, gender, household status, severity of disease, and previous treatment with mechanical ventilation, seemed to affect patients' preferences.
Introduction
Respiratory diseases are significant contributors to morbidity and mortality. In Portugal, the mortality rate due to respiratory diseases increased from 101.8 out of 100,000 individuals in 2007 to 108. 4 out of 100,000 individuals in 2010. 1 According to data from World Health Organization, among respiratory diseases chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide, 2 and some studies have predicted that COPD will become the third or fourth leading cause of death by 2030. 3, 4 Indeed, in the USA, death rates from COPD increased dramatically from 1999 to 2009. 5 Exacerbation with acute-on-chronic respiratory failure is an important cause of unscheduled physician visits and prolonged hospitalisation 6 and is associated with a high risk of complications. In these situations, patients' knowledge and preferences regarding lifesustaining treatment (LST) fuel an on-going debate on end-of-life ethics in many fields, namely, medical futility and distributive justice. 7, 8 Some literature has provided directives for end-of-life care (ELC) in hospital settings, primarily in intensive care units in the USA. 9 However, end-of-life ethics vary according to sociocultural environments in various countries. 10 Thus, it is important to develop an understanding of the different views of patients and physicians worldwide on the topic of ELC. 9, 11 Besides cultural differences, patients' options for LSTs should be presented in the form of a synopsis of various perspectives that may help the patient to make a decision. 12 For example, the physician should consider the timing of the discussion, nature of the illness, quality of life, ELC, and prognosis. 13, 14 Despite the frequency of chronic respiratory diseases, very few studies have been performed in patients when they are clinically stable or during an exacerbation event. 15 From the patient's perspective, it would be most appropriate to make a choice regarding LST during advanced stages of the disease 16, 17 since it is in these stages that the burden of suffering is greater and can be limiting on the daily activities, thus influencing their quality of life.
The aim of this prospective, observational, exploratory study was to identify the demographic and disease-related variables that influence the LST preferences of patients with chronic respiratory diseases in a clinically stable situation and during their regular and scheduled outpatient follow-up visits.
Methods

Study subjects
This was a single-centre, prospective, exploratory, observational study that addressed patients with chronic respiratory diseases affecting the airways, lung parenchyma, and/or chest wall. Patients with inclusion parameters were approached by their pulmonologists and enrolled based on their availability, willingness to volunteer, and ease of access (for convenient sampling). Patients provided verbal informed consent in the presence of a family member. The inclusion parameters were as follows: at least 18 years old, having endstage pulmonary diseases, requiring long-term oxygen therapy (LTOT) with or without noninvasive mechanical ventilation (NIMV), dyspnoea score of 6 or more using the modified Borg dyspnoea scale, and one of the following: Gold (COPD classification) stage IV, diffusing capacity (DLCO) less than 40%, New York Heart Association functional classification (NYHA) stage III/ IV or higher, or pulmonary hypertension with systolic pulmonary artery pressure (sPAP) greater than 40 mmHg. Patients with cystic fibrosis, neuromuscular diseases, or oncologic pathology were excluded. The study was approved by the Ethics Committee of Santa Maria Hospital and was authorised by the National Committee of Data Protection.
Demographic parameters
The following data were recorded for each patient: age, gender, race, residency, religion, household status, occupation, literacy level (according to the an alphabets/IV standard of education), previous invasive mechanical ventilation and main pathology.
Patient interviews
The patients were interviewed by six senior or consultant pulmonologists at the out-patient clinic of Pulmonology Department of Saint Mary University Hospital in Lisbon city (Portugal), attending predominantly urban, but also rural patients, over a three-year period (January 2007 to December 2010). A survey was conducted by the patient's pulmonologist during regular follow-up visits, with the patient in a clinically stable condition and after assuring the patient that the answers would not be considered in any decisions regarding LSTs. The same questionnaire was used by the interviewers and the patients approached agreed to participate. If needed, the clinical and demographic data were used from the medical record of the patient.
For the survey the patient was asked a single question, "Considering the stage of your disease, in case of an exacerbation would you agree with following treatment?" for the following scenarios:
A. Temporary invasive mechanical ventilation B. Temporary tracheostomy C. Tracheostomy and invasive home mechanical ventilation D. Temporary haemodialysis E. Cardiopulmonary resuscitation It was explained to the patient and family member that all of these treatments require invasive procedures and are life-saving. However, with the exception of treatment C (tracheostomy and invasive home mechanical ventilation), all the other treatments are temporary treatments. Therefore, the patient understood that successful application of the treatment (except treatment C) would not lead to a poor quality of life (would lead a normal life, the one they had before being submitted to LST's), and answered the survey only after considered himself fully enlightened.
For each of the scenarios (A-E), the patient was asked to choose from the following: 
Statistical analysis
The study design, procedures, and results were monitored by an independent statistical consultancy agency (Data Science Consultores, Lda.). The results were analysed with descriptive univariable and bivariable statistics, using the average, standard deviation, and median for the quantitative variables and counts and percentages for the qualitative variables. The significance of the association between two qualitative variables was assessed using the chi-square independence test or the Fisher exact test. Considering multiple comparisons, Bonferroni corrections were applied. All tests were two-sided, and with these corrections (Bonferroni) p values of less than 0.05 that were considered statistically significant are only considered significant for values less than 0.010 (unless otherwise stated). All statistical analyses were performed using SPSS version 19 software (SPSS; Chicago, IL).
Results
Baseline characteristics of the patients
A total of 106 patients were included in the study. Demographics are given in Table 1 . Most patients were elderly individuals (median age: 70 years; range: 38-91 years), and there was no significant difference in gender. Patients were mostly (95%) Caucasians and urban dwellers, had a low educational level and considered themselves religious.
COPD accounted for the majority of patients (60%), while pulmonary tuberculosis sequelae, interstitial lung diseases (pulmonary fibrosis), and a miscellaneous group comprising bronchiectasis, kyphoscoliosis, and other diseases accounted for the remaining 40% ( Figure 1 ). Advanced-stage chronic respiratory failure was evident when various objective (pulmonary function tests 18 or sPAP) or subjective (dyspnoea evaluated by Borg scale or NYHA classification) variables were analysed. A forced expiratory volume (FEV) less than 30% was observed in 33% (31/93) and diffusion in less than 40% (7/20) of patients. Moreover, 65% (68) of patients had severe to maximal (7-10) dyspnoea in the Borg scale. Heart failure (stage III/IV of NYHA) was present in 67 of 106 patients, while 51% (45) of patients had a sPAP of 40 mmHg or more. Sixty per cent of patients were on LTOT, and the remaining 40% were on LTOT and noninvasive ventilation.
Survey analysis
The responses of patients to the question "Considering the stage of your disease, in case of an exacerbation would you agree with following treatment?" were compiled into three main categories, for each of the five answers (A-E):
a. Certainly yes: only those who would accept undoubtedly the treatment b. Certainly no: only those who would refuse undoubtedly the treatment Figure 1 . Patient pathologies. The numbers and percentages of patients with pulmonary fibrosis, pulmonary tuberculosis sequelae, chronic obstructive pulmonary disease and other diseases.
c. Probably yes/Probably no/Do not know/Did not answer: those who were not in 'a' or 'b' option Table 2 shows that most patients would accept option A (76%; temporary invasive mechanical ventilation), option D (73%; haemodialysis), and option E (86%; cardiopulmonary resuscitation). On the other hand, for LST involving tracheostomy, 63% of patients would agree to temporary tracheostomy with invasive mechanical ventilation (option B; p < 0.0001), and only 24% of patients would accept definitive tracheotomy with invasive home mechanical ventilation (option C; p < 0.252). For some patients who refused this option, they assumed that they had already experienced enough suffering "I am tired of living" and that some treatments are acceptable at the hospital but not at home. "My house has no conditions for this type of treatments"
Impact of demographic and cultural parameters
The characteristics of the patients who would agree to the permanent debilitating condition of option C provided insightful information into the cultural beliefs of the Portuguese population. Most patients who would accept the treatment were men (56%; n ¼ 14), old-aged (76 years; 56%; n ¼ 14), and living in urban areas (84%; n ¼ 21). Moreover, of the entire patient population, 92% (n ¼ 23) considered themselves religious, and 20% (n ¼ 5) of patient agreeing to the treatment had experienced at least one prior treatment with mechanical ventilation. COPD was the diagnosis in 52% (n ¼ 13) of patients.
When the option of definitive tracheostomy with home mechanical ventilation (option C) was further examined, the results showed that there was no statistically significant difference among the options (p ¼ 0.252).
Interestingly, 83% and 100% of patients would agree to temporary haemodialysis (n ¼ 20) and cardiopulmonary resuscitation (n ¼ 24).
Inferential analysis. For inferential data analysis, the five treatments were examined according to demographics and disease severity parameters, as shown in Table 3 . After Bonferroni correction, no statistical differences were found between each treatment and these parameters. However, a more pronounced difference was observed in some groups, as was the case with the decision to receive temporary invasive ventilation that had a more pronounced difference by gender, because most patients who would agree to this treatment were men (p ¼ 0.024; n < 5%). The same was observed with regarding household status. Patients living alone, who would reject any type of LST (p ¼ 0.05, <5%), after Bonferroni correction showed a more pronounced difference, however, not statistically significant).
With regard to age, 34% of patients who would accept temporary haemodialysis were in the range of 18 to 65 years (p ¼ 0.083, <10%).
When previous treatments with ventilation were considered, the independence between previous mechanical ventilation and temporary haemodialysis was rejected. Although a significant majority (83%) of patients without a previous episode of mechanical ventilation would agree with temporary haemodialysis, 12% would reject it. However, all (100%) patients with a previous episode of mechanical ventilation would agree to temporary haemodialysis (p ¼ 0.018, <5%). In this case also it was observed a more pronounced difference since patients with a previous episode of mechanical ventilation were more willing to accept temporary haemodialysis as well. Regarding temporary tracheostomy and invasive mechanical ventilation (p ¼ 0.073, <10%), with the exception of a single patient, all those who had a previous episode of mechanical ventilation would agree with temporary tracheostomy and invasive mechanical ventilation.
When disease severity was considered, the independence between dyspnoea and temporary MV was rejected since those who would agree (84%, n ¼ 42) were in class III (p ¼ 0.085, <10%), while those who would not agree or did not have an opinion represented 63% (n ¼ 10) of individuals. The same trend was observed when cardiopulmonary reanimation was considered. Among patients who would agree (n ¼ 47) with this LST, 84% were in class III of NYHA (p ¼ 0.029, <5%), compared with 50% (n ¼ 5) for patients who would reject the treatment or did not have an opinion. Once again, there was a pronounced difference in patients in class III of NYHA who were more willing to receive LST. The economic impact was not considered in the LST preferences because at the time of the study almost all the expenses were covered by the national health service.
Discussion
The aims of this study were to evaluate patients' acceptances for LST in case of exacerbation of chronic respiratory diseases when they were in a clinically stable situation. In short, the timing to inquiry about LST and the patients consent or refusal.
Is this the proper time and are these the proper questions?
In our opinion yes. In acute exacerbations of advanced chronic respiratory diseases there is every possibility that the patient may require LST, namely invasive mechanical ventilation, tracheostomy, haemodialysis and cardiopulmonary resuscitation. These treatments and their consequences can be temporary or definitive and, as such, with a burden on the quality of life not only of the patient himself but also of his family.
On the other hand, the patient should be inquired about his opinion when he is, as much as possible, free of any emotion and not vulnerable and fragile as he will, presumably, be when he is admitted to an intensive care unit. This is the time to translate the principle of autonomy and the informed consent into acts.
Any study with these characteristics should also determine the impact of some demographic and clinical variables on these preferences. The studies of demographic variables are relevant since they allow a more detailed insight and analysis of the cultural impact of such preferences and a possibility to compare such preferences with observations in studies of different populations.
Regarding the answers to the questions, they had no polarised framing; the patients were given all the options possible; to accept, to refuse or they did not know, had no answer or were unsure.
One major observation in this study was that there was a clear difference in preference regarding LSTs with temporary consequences versus those with permanent consequences. Indeed, most patients would accept temporary LSTs, but no clear consensus was reached for permanent LSTs. Moreover, while several factors influenced patient preferences for temporary LSTs, for LSTs that were considered permanent, the only variable that seemed to affect the preference was the household status; those who lived alone had a more pronounced rejection of treatment with permanent consequences.
Gender seemed to influence temporary invasive mechanical ventilation since in most patients there was a more pronounced acceptance of this kind of treatment by men. (Table 3) The reason for this is not clear. However, it is possible that women believed that they have reached the limit of their suffering or that their quality of life was reduced. Alternatively, this may be because women have been shown to be less likely to accept active options, do not want to burden their families, and are more risk averse. 13 Temporary invasive mechanical ventilation was also influenced by disease severity; patients with severe dyspnoea rejected temporary invasive mechanical ventilation. It is possible that these patients had reached the limit of suffering. Finally, patients living alone also rejected temporary invasive mechanical ventilation.
In temporary haemodialysis a more pronounced rejection was observed by patients living alone, but favoured by patients with a previous successful experience with mechanical ventilation. Moreover, this study revealed that there was a more significant difference in adults (18-65 years of age) than other age groups, to accept the temporary haemodialysis. Studies of patients who are dependent on dialysis have suggested that the elderly (77 years of age) are most likely to refuse dialysis. 19, 20 However, these studies were carried out with patients on chronic haemodialysis with end-stage renal disease, not in the context of acute renal failure as a complication of acute-onchronic respiratory failure or with dialysis as a temporary treatment.
Interestingly, cardiopulmonary resuscitation was rejected by patients with severe dyspnoea (class IV of NYHA). Moreover, age did not affect the preference toward cardiopulmonary resuscitation. This was consistent with a study investigating the attitudes of patients with COPD, surveyed at home, with inclusion factors 21 similar to those of the current study. However, a different perspective was observed in another study with patients hospitalised for exacerbation of severe congestive heart failure, wherein resuscitation refusal was more frequent in older patients, those who had a perception of a worse prognosis (expressed as likelihood of living for at least 2 months), those who had a poorer activity status within the two weeks before admission, and those with higher incomes. 22 Notably, in this study, a substantial proportion of patients who did not want to be resuscitated changed their minds within two months of discharge, suggesting that the situation/location in which the patient is questioned may affect the response. Such an effect has been observed in patients with advanced lung cancer and severe COPD, 23 in which 78% of hospitalised patients with COPD were extremely unwilling to receive mechanical ventilation indefinitely. Although it is clear that COPD patients need to have such end-of-life discussions, 17 few patients (13%) will provide an answer when they are not hospitalised. 24 The LST involving temporary tracheostomy with invasive mechanical ventilation was accepted by patients with an identical successful previous episode. Thus, patients who had survived a past experience with mechanical ventilation were more willing to accept new invasive ventilation, even if it involved a temporary tracheostomy for them to be ventilated. A similar result reported in a study of survivors of prolonged mechanical ventilation through a tracheostomy. 25 Again, these data showed that previous experiences could influence our choices, mostly in a positive direction, if the experience had a successful outcome. As with all other LSTs, those living alone had a more profound rejection for this treatment.
In this study, of the demographic variables, household status seemed to have a significant influence independent of the LST. The emotional sense of loneliness and eventually no reason to live could influence the preference for rejection or acceptance of any kind of LST in patients with end-stage chronic respiratory diseases. Other demographic variables, such as education and religion, had no statistically significant effect on the preferences of patients toward any LST. In the case of education, this observation might be explained by the low literacy level of the participants, and in the case of religion, this observation might be explained by the small number of those who considered themselves agnostics or atheist. These conjectures will need to be examined in future studies.
Technological advances in medicine have changed the natural history of many diseases. For pulmonary pathology, respiratory failure is the ultimate path to death and can be delayed by mechanical devices (i.e. ventilators), such that patients can die from some other disease or eventually receive a transplant. 26 However, the main problem with chronic respiratory disease is that it generally progresses through exacerbation events, which often require intensive care support, to cardiorespiratory failure and finally death. 27 During its trajectory, the burden of suffering can make everyday life completely unbearable. Moreover, the disease can cause economic hardship, 28 making the patient feel like a burden to his or her family. However, most patients in this study were willing to accept LSTs.
Some limitations in this study should be acknowledged. First, the small number of answers for some groups, namely those with a previous episode of mechanical ventilation, may have been a source of bias. Although the patients were assured that this was only an observational study and that their answers would not be considered for any treatment options, the results should be interpreted with caution. Another drawback was the exclusion of two variables that are generally analysed in studies of LSTs: prognosis and depression. Prognosis was not examined in this study because although the overall prognosis in endstage chronic respiratory diseases is quite dismal, the outcome of an exacerbation, when it requires intensive care and therefore LST, is unpredictable. Moreover, it is well known that these patients are emotionally fragile and prone to depression. 29, 30 In this study, we did not consider the impact of depression because all patients in this study were on either antidepressant or tranquilisers.
In this study, which was performed only in patients with chronic respiratory diseases, patient responses were evaluated in a clinically stable situation; some factors that can influence patients' preferences for a particular LST were identified. Primarily, this study showed that patients were more willing to accept temporary treatment, while the reverse was observed with patients who lived alone who tended to reject all possible treatments. Other variables, such as gender, age, disease severity, and previous experience with mechanical ventilation, also influenced some treatment preferences. Further analyses of other demographic variables, such as education and religion, should be carried out and considered in discussions with patients.
Conclusion
Discussions regarding LST preferences should consider the timing, the way they are approached and the demographic and clinical variables that can influence the outcome.
The decision should result from a continuum of conversations between the physician and the patient and should not be restricted to any particular moment of a previously scheduled appointment.
In this study a deeper difference was observed regarding the consequences of the treatment, permanent versus definitive, and the household status (loneliness).
